PLoS ONE (Jan 2016)

Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells.

  • Arlet M Acanda de la Rocha,
  • Hernando López-Bertoni,
  • Elizabeth Guruceaga,
  • Marisol González-Huarriz,
  • Naiara Martínez-Vélez,
  • Enric Xipell,
  • Juan Fueyo,
  • Candelaria Gomez-Manzano,
  • Marta M Alonso

DOI
https://doi.org/10.1371/journal.pone.0163155
Journal volume & issue
Vol. 11, no. 9
p. e0163155

Abstract

Read online

INTRODUCTION:Glioblastoma is the most malignant brain tumor in adults and is associated with poor survival despite multimodal treatments. Glioma stem-like cells (GSCs) are cells functionally defined by their self-renewal potential and the ability to reconstitute the original tumor upon orthotopic implantation. They have been postulated to be the culprit of glioma chemo- and radio-resistance ultimately leading to relapse. Understanding the molecular circuits governing the GSC compartment is essential. SOX2, a critical transcription regulator of embryonic and neural stem cell function, is deregulated in GSCs however; the precise molecular pathways regulated by this gene in GSCs remain poorly understood. RESULTS:We performed a genome-wide analysis of SOX2-regulated transcripts in GSCs, using a microarray. We identified a total of 2048 differentially expressed coding transcripts and 261 non-coding transcripts. Cell adhesion and cell-cell signaling are among the most enriched terms using Gene Ontology (GO) classification. The pathways altered after SOX2 down-modulation includes multiple cellular processes such as amino-acid metabolism and intercellular signaling cascades. We also defined and classified the set of non-coding transcripts differentially expressed regulated by SOX2 in GSCs, and validated two of them. CONCLUSIONS:We present a comprehensive analysis of the transcriptome controlled by SOX2 in GSCs, gaining insights in the understanding of the potential roles of SOX2 in glioblastoma.